NasdaqGS:NVAXBiotechs
Novavax (NVDA) Could Be 42% Undervalued Following Losses And Shelf Registration
What the latest Novavax earnings mean for shareholders
Novavax (NVAX) just delivered a sharp turn in its financial story. Second quarter 2026 results showed revenue of US$56.7 million and a shift from net income to a net loss, alongside a fresh shelf registration filing.
See our latest analysis for Novavax.
The latest earnings release and shelf registration have come alongside mixed recent trading for Novavax. The share price has risen 2.71% over the last day and 8.61% over the past week,...